Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Dexedrine Spansule

(Dextroamphetamine Sulfate)

Small molecule

NNoven Pharmaceuticals, Inc.

0

Indications

1

Total Trials

0

Active Trials

0

Competitors

2

FDA Applications

NDA/BLA/ANDA regulatory filings

Clinical

Trials by Indication[1]

Unspecified1 trial

Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release

Unknown status·MMedical University of Vienna·N/A·NCT03223844·22 enrolled

Regulatory

FDA Approval Timeline[3]

Jan 1, 1982

DEXEDRINE SPANSULE

NDA NDA017078

Mar 22, 2022

XELSTRYM

NDA NDA215401

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dextroamphetamine Sulfate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dextroamphetamine Sulfate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA215401). U.S. Food & Drug Administration.
[4]
SEC EDGAR — Noven Pharmaceuticals, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: NNoven Pharmaceuticals, Inc.

Related News